Oncoloxía médica
Servizo
Centro Nacional de Investigaciones Oncológicas
Madrid, EspañaPublicacións en colaboración con investigadores/as de Centro Nacional de Investigaciones Oncológicas (18)
2023
2022
-
Macrophages direct cancer cells through a LOXL2-mediated metastatic cascade in pancreatic ductal adenocarcinoma
Gut, Vol. 72, Núm. 2, pp. 345-359
2021
-
Aberrant integration of Hepatitis B virus DNA promotes major restructuring of human hepatocellular carcinoma genome architecture
Nature Communications, Vol. 12, Núm. 1
2020
-
Exploiting oxidative phosphorylation to promote the stem and immunoevasive properties of pancreatic cancer stem cells
Nature Communications, Vol. 11, Núm. 1
2019
-
A multifunctional drug nanocarrier for efficient anticancer therapy
Journal of Controlled Release, Vol. 294, pp. 154-164
-
Clinical utility of plasma-based digital next-generation sequencing in oncogene-driven non-small-cell lung cancer patients with tyrosine kinase inhibitor resistance
Lung Cancer, Vol. 134, pp. 72-78
-
Clinical utility of plasma-based digital next-generation sequencing in patients with advance-stage lung adenocarcinomas with insufficient tumor samples for tissue genotyping
Annals of Oncology, Vol. 30, Núm. 2, pp. 290-296
-
Phase I/II trial to evaluate the efficacy and safety of nanoparticle albumin-bound paclitaxel in combination with gemcitabine in patients with pancreatic cancer and an ECOG performance status of 2
Journal of Clinical Oncology
-
Tumor-associated macrophage-secreted 14-3-3ζ signals via AXL to promote pancreatic cancer chemoresistance
Oncogene, Vol. 38, Núm. 27, pp. 5469-5485
2017
-
Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain
Clinical and Translational Oncology, Vol. 19, Núm. 6, pp. 667-681
2015
2013
2012
-
Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
Breast Cancer Research and Treatment, Vol. 132, Núm. 1, pp. 307-315
-
EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours
Scientific Reports, Vol. 2
2009
-
Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma
Cancer Research, Vol. 69, Núm. 3, pp. 1099-1108
-
Transgenic mice expressing constitutively active akt in oral epithelium validate KLFA as a potential biomarker of head and neck squamous cell carcinoma
In Vivo, Vol. 23, Núm. 5, pp. 653-660
2008
-
The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain
Clinical Cancer Research, Vol. 14, Núm. 9, pp. 2861-2869
2005
-
Cell-cycle-associated markers and clinical outcome in human epithelial cancers: A tissue microarray study
Oncology Reports, Vol. 14, Núm. 6, pp. 1527-1531